國立高雄大學圖資館 |

登入

回首頁

Animal models for the development of cancer immunotherapy

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Animal models for the development of cancer immunotherapyedited by Seng-Lai Tan.
其他作者:	Tan, Seng-Lai.
出版者:	Hoboken, NJ :Wiley,2022.
面頁冊數:	1 online resource.
標題:	TumorsTreatment.
電子資源:	https://onlinelibrary.wiley.com/doi/book/10.1002/9781119535331
ISBN:	9781119535331$q(electronic bk.)

Animal models for the development of cancer immunotherapy
Animal models for the development of cancer immunotherapy[electronic resource] /edited by Seng-Lai Tan. - Hoboken, NJ :Wiley,2022. - 1 online resource.

Includes bibliographical references and index.

"There has been an explosion of preclinical and clinical research leading to FDA approvals of immunotherapies that harness or enhance a patient's immune system to target tumors. However, despite promising clinical results, checkpoint blockade therapies can show intrinsic and acquired resistance and only certain tumor types respond more favorably than others. Animal models are valuable tools for studying these issues and for the preclinical evaluation of immune modulators"--

ISBN: 9781119535331$q(electronic bk.)Subjects--Topical Terms:

275878
Tumors
--Treatment.

LC Class. No.: SF910.T8 / A55 2022

Dewey Class. No.: 636.089/6994

National Library of Medicine Call No.: QZ 266

Animal models for the development of cancer immunotherapy
LDR:01562cmm a2200325 a 4500 001 650418
003 OCoLC
005 20221202042454.0
006 m o d
007 cr cnu---unuuu
008 240227s2022 nju ob 001 0 eng
020 $a 9781119535331$q(electronic bk.)
020 $a 1119535336$q(electronic bk.)
020 $a 9781119535317$q(epub)
020 $a 111953531X$q(epub)
020 $a 9781119535270$q(ePDF)
020 $a 1119535271$q(ePDF)
020 $z 9781119535287$q(hbk.)
035 $a 1341342966
040 $a DLC $b eng $c DLC $d YDX $d OCLCF $d DG1
041 0 $a eng
050 0 0 $a SF910.T8 $b A55 2022
060 0 0 $a QZ 266
082 0 0 $a 636.089/6994 $2 23
245 0 0 $a Animal models for the development of cancer immunotherapy $h [electronic resource] / $c edited by Seng-Lai Tan.
260 $a Hoboken, NJ : $b Wiley, $c 2022.
300 $a 1 online resource.
504 $a Includes bibliographical references and index.
520 $a "There has been an explosion of preclinical and clinical research leading to FDA approvals of immunotherapies that harness or enhance a patient's immune system to target tumors. However, despite promising clinical results, checkpoint blockade therapies can show intrinsic and acquired resistance and only certain tumor types respond more favorably than others. Animal models are valuable tools for studying these issues and for the preclinical evaluation of immune modulators"-- $c Provided by publisher.
588 $a Description based on print version record.
650 0 $a Tumors $x Treatment. $3 275878
650 1 2 $a Neoplasms $x therapy. $3 197598
650 2 2 $a Immunotherapy $x methods. $3 340356
650 2 2 $a Disease Models, Animal. $3 265387
700 1 $a Tan, Seng-Lai. $3 751944
856 4 0 $u https://onlinelibrary.wiley.com/doi/book/10.1002/9781119535331